Medtronic Vascular recalls specific SHERPA NX Active Guiding Catheters for potential wire exposure risk. Affected units may have stainless-steel braid wires exposed, requiring immediate action.
There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.
Medtronic Vascular is recalling certain SHERPA NX Active Guiding Catheters used in cardiovascular procedures. The recall is due to a risk of stainless-steel braid wires becoming exposed, which could cause serious complications during procedures.
The catheter's primary segment material may degrade, exposing the underlying stainless-steel braid wires. This could lead to complications like kinking or blockages during procedures, potentially causing serious injury.
Cardiovascular doctors and medical professionals who use the recalled catheters are most at risk. Patients undergoing procedures with these catheters may also be affected.
Check for the model: SHERPA NX ACTIVE GUIDING CATHETER, 6F, JR4.0, 90CM, 070", REF SA6JR40D. The product was sold with GTIN: 00613994822307 and all lot/serial numbers.
Verify the model and serial numbers against the recall list to confirm if your catheter is affected.
The recall states there is a potential risk of wire exposure, so affected units should not be used until the remedy is applied.
Contact Medtronic Vascular directly to confirm if your specific catheter is affected and follow their instructions.
Look for the model: SHERPA NX ACTIVE GUIDING CATHETER, 6F, JR4.0, 90CM, 070", REF SA6JR40D. The product was sold with GTIN: 00613994822307 and all lot/serial numbers.
We’ve drafted a message you can send Medtr: a short, human brand name for headings (e.g. "Trsmima") to request your refund or repair — edit it as you like.
Subject: Recall Z-2593-2019 — Medtr: a short, human brand name for headings (e.g. "Trsmima") Medtr: a short, human brand name for Hello, I own a Medtr: a short, human brand name for headings (e.g. "Trsmima") that is covered by recall Z-2593-2019 from Medtr: a short, human brand name for headings (e.g. "Trsmima"). I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
